Published on: September 29, 2026
Heart failure remains one of the leading causes of costly hospital admissions, with persistent congestion driving emergency visits, readmissions and significant symptom burden – even as advances in therapy continue. Traditional care models often intervene too late, relying on inpatient intravenous diuresis when oral medications fail, and leaving a critical gap for patients with chronic kidney disease or those at risk of diuretic resistance. The Centers for Medicare & Medicaid Services (CMS) Ambulatory Specialty Model (ASM) for HF further raises the stakes, shifting accountability and financial risk to the ambulatory setting and making avoidable hospitalizations and emergency department visits a direct threat to program performance.
Drawing on real-world experience from Cone Health and Emory Health System, a webinar and roadmap will provide a scalable framework for cardiovascular leaders seeking to implement home-based decongestion with FUROSCIX® (furosemide injection) safely, efficiently and in alignment with CMS ASM and value-based care.
Download the roadmap here for more details:
https://www.medaxiom.com/publications/cv-business-white-papers/#row751276
By continuing to use our site, you agree to our Cookie Policy, Privacy Policy and Terms of Use.
